Lite Strategy, Inc. (LITS) Stock Score, Valuation & Financial Research

Lite Strategy, Inc. is in the Healthcare sector and Biotechnology industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. A complete Wall Street Score is not currently available.

Quick answer for LITS

Lite Strategy, Inc. does not currently have a complete Wall Street Score. The stored market price is USD 1.41. These figures are a research snapshot, not a buy or sell recommendation.

What Lite Strategy, Inc. does

Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.

Company business and revenue

Research reporting period: 2026-06-30. A research update is not a new financial filing.

How the company makes money

Lite Strategy, Inc. operates as a holding company that has transitioned from a clinical-stage oncology pharmaceutical developer to a firm focused on a digital-asset treasury strategy. The company maintains legacy oncology drug assets while actively managing a treasury reserve primarily composed of Litecoin (LTC) to increase the backing behind its common stock.

Products and services

  • The company holds legacy oncology drug assets and manages a corporate treasury reserve consisting of Litecoin (LTC) digital assets.

Business strengths to evaluate

  • Adoption of a digital-asset treasury strategy focused on Litecoin (LTC) reserves. Source

Business risks and research considerations

  • Market volatility and regulatory risks associated with digital asset holdings. Source

Sources: Company research source · Adoption of a digital-asset treasury strategy focused on Litecoin (LTC) reserves.

Company research refreshed 2026-10-13. This is saved research, not a live check of company relationships. Check the reporting period and source disclosures. Financial figures and scores follow their separate update schedules.

LITS financial snapshot

Statement amounts: USD. Quote amounts: USD. No exchange-rate conversion is performed in this snapshot. Market-capitalization currency is not supplied by this projection.

Wall Street Score:
Not currently available
Stored price:
USD 1.41
Market capitalization:
47.98M (currency not supplied)
Revenue:
USD 0.00
Net income:
USD -71.15M
Free cash flow:
USD -9.12M
Cash:
USD 5.71M
Total debt:
USD 0.00
EPS:
USD -9.11

What stands out

  • Free cash flow is USD -9.12M, negative for the stored period.
  • The balance sheet shows USD 5.71M of cash versus USD 0.00 of total debt, an excess of cash over debt on these two reported measures.
  • The current research record carries a fundamental change risk warning, which should be reviewed alongside the score.

Company-specific financial comparisons

The following are calculated from saved company data, not forecasts or statements about future performance. Differences in reporting dates or units can make a ratio misleading; verify the original filings.

  • Cash exceeds debt by USD 5.71M using the stored balance-sheet values. This does not include other obligations or restricted cash.

Questions worth answering for LITS

Use these questions to check the stored figures against the latest company filings. They identify issues to investigate; they are not findings about management's plans or future results.

  • How long can LITS fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is LITS likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for LITS to reach sustainable profitability?
  • What does the current fundamental change risk warning mean for the reliability or interpretation of LITS's score?

What the numbers mean

A complete valuation score is not currently available, so valuation should be checked using the available earnings, cash-flow and price data.

A complete financial score is not currently available, so investors should review cash, debt, earnings and cash flow directly.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-10-01.

Research-input completeness: 64% of the scoring inputs required for this public page are currently available.

How to research LITS

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.